Indication-based use of antimicrobials in Finnish primary health care: Description of a method for data collection and results of its application

Scandinavian Journal of Primary Health Care

Volumn 17, Issue 2, 1999, Pages 93-99

  Rautakorpi, Ulla Maija ^a   Lumio, Jukka ^b   Huovinen, Pentti ^c   Klaukka, Timo ^d  

^a Pirkkala Health Centre   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d SOCIAL INSURANCE INSTITUTION   (Finland)

Author keywords

Antibiotics; Infection; Primary health care; Treatment

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; MACROLIDE; PENICILLIN DERIVATIVE; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; BRONCHITIS; CHILD; DATA ANALYSIS; DRUG INDICATION; FEMALE; FINLAND; GENERAL PRACTITIONER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OTITIS MEDIA; PHARYNGITIS; PRIMARY HEALTH CARE; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION; TONSILLITIS;

ADOLESCENT; AGED; ANTI-BACTERIAL AGENTS; ATTITUDE TO HEALTH; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; DRUG UTILIZATION; FEMALE; FINLAND; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; PRESCRIPTIONS, DRUG; PRIMARY HEALTH CARE; QUESTIONNAIRES;

EID: 0032800744     PISSN: 02813432     EISSN: None     Source Type: Journal    
DOI: 10.1080/028134399750002719     Document Type: Article

References (25)

1. Finnish Statistics on Medicines 1994. Helsinki: National Agency for Medicines and The Social Insurance Institution, 1995.
2. Nordic Statistics on Medicines 1993-1995. Uppsala: Nordic Council on Medicines, 1996.
3. Neu HC. The crisis in antibiotic resistance. Science 1992;257:1064-73.
4. Søgaard P. The epidemiology of antibiotic resistance in three species of the Enterobacteriaceae and the relation to consumption of antimicrobial agents in Odense University Hospital. Dan Med Bull 1989;36:65-84.
5. Gerding DN, Larson TA, Hughes RA, Weiler M, Shanholtzer C, Peterson LR. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 1991;35:1284-90.
6. Seppälä H, Klaukka T, Lehtonen R, Nenonen E, The Finnish Study Group for Antimicrobial Resistance, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in group A Streptococci. Clin Infect Dis 1995;21:1378-85.
7. Arason VA, Kristinsson KG, Sigurdsson JA, Stefánsdóttir G, Mölstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 1996;313:387-91.
8. Stingemore N, Francis GRJ, Toohey M, McGechie DB. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med J Aust 1989;150:626-27, 630-1.
9. Seppälä H, Nissinen A, Järvinen H, Huovinen S, Henriksson T, Herva E, et al. Resistance to erythromycin in group A Streptococci. N Engl J Med 1992;326:292-7.
10. Baquero F, Martinez-Beltran J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991;28 (Suppl C):31-8.
11. Reichler MR, Allphin AA, Breiman RF, Schreiber JR, Arnold JE, McDougal LK, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-53.
12. Rosdahl VT, Westh H, Jensen K. Antibiotic susceptibility and phage type pattern of Staphylococcus aureus strains isolated from patients in general practice compared to strains from hospitalized patients. Scand J Infect Dis 1990;22:315-20.
13. Kristinsson KG, Hjalmarsdottir MA, Steingrimsson O. Increasing penicillin resistance in pneumococci in Iceland. Lancet 1992;339:1606-7.
14. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993;168:158-63.
15. Kalin M. Antibiotikaresistens hos pneumokocker. Hotfull utveckling i allt fler länder (Antibiotic resistance in pneumococci. A threatening development in more and more countries). Läkartidningen 1994;91:2219-22.
16. Gibbons A. Exploring new strategies to fight drug-resistant microbes. Science 1992;257:1036-8.
17. Travis J. Reviving the antibiotic miracle. Science 1994;264:360-2.
18. Orr P, Scherer K, McDonald A, Moffat M. Randomized placebo-controlled trials of antibiotics for acute bronchitis: a critical review of the literature. J Fam Pract 1993;36:507-12.
19. Jørgensen AF, Coolidge J, Pedersen PA, Petersen KP, Waldorff S, Widding E. Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis. Scand J Prim Health Care 1992;10:7-11.
20. Gonzales R, Sande M. What will it take to stop physicians from prescribing antibiotics in acute bronchitis? Commentary. Lancet 1995;345:665.
21. Zwar NA, Gordon JJ, Sanson-Fisher RW. Antibiotic and benzodiazepine prescribing by general practice trainees. Med J Aust 1994;161:491-3.
22. Melbye H. Klarer vi å redusere bruken av antibiotika ved akutt bronkitt? (Are we managing to reduce the use of antibiotics in acute bronchitis?). Tidsskr Nor Lægeforen 1995;115:1930-1.
23. Huovinen P, Klaukka T. Erytromysiinin käyttöä vähennettävä (The use of eryhtromycin must be reduced). Suom Lääkäril 1991;46:3241.
24. Lumio J. Montako antibioottia terveyskeskuslääkäri tarvitsee? (How many antibiotics do a health centre GP need?). Suom Lääkäril 1996;51:3133-5.
25. Friis H. Sulfa med trimetoprim - en farlig kombination (Sulpha and trimethoprim - a dangerous combination). Ugeskr Læger 1987;149:2563-5.